Tekast10: Each film coated tablet contains Montelukast Sodium USP equivalent to 10 mg Montelukast.
Tekast5: Each chewable tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.
Tekast is indicated for the prophylaxis and chronic treatment of asthma in adults and children.
|6 months - 6 years||4mg/day, in the evening|
|6 years - 15 years||5mg/day, in the evening|
|15years and older||10mg/day, in the evening|
Tekast (Montelukast) may be taken With or Without food.
Montelukast has been generally well tolerated. Side effects, which usually are mild, including gastro-intestinal disturbances, dry mouth, thirst; hypersensitivity reactions including anaphylaxis, angioedema and skin reactions; asthenia, dizziness, irritability, restlessness, headache, sleep disorders (insomnia, drowsiness, nightmares); upper respiratory tract infection, fever, arthralgia, myalgia. The overall incidence of side effects reported with montelukasl was comparable to placebo.
Tekast10: Each box contains 2 x 10’s tablet in blister pack.
Tekast5 : Each box contains 2 x 10’s tablet in blister pack.